DexCom Earnings Estimates, EPS & Revenue | NASDAQ:DXCM

Comments

DexCom Inc Earnings Estimates

DXCMNASDAQ

Trade with Public

$62.76

-0.19-0.30%

Last update: Apr 15, 8:32 AM

Overview NewsEarningsOptions Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

DexCom Earnings Estimates, EPS & Revenue | NASDAQ:DXCM

DexCom (DXCM) is scheduled to report Q1 earnings on April 30, 2026. Analysts estimate EPS of $0.47 and quarterly revenue of $1.18B.

In the most recent quarter (Q4), DexCom reported EPS of $0.68, beating estimates of $0.65 by 0.05%. Revenue came in at $1.26B, exceeding the estimate of $1.25B by 0.01%.

DexCom has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, DexCom has averaged an EPS surprise of 0.05% and a revenue surprise of 0.02%.

Earnings Date

Apr 30

EPS Estimate

$0.470

Quarterly Revenue Estimate

$1.18B

Annual Revenue
(as of Dec 31)

$4.66B

DexCom Earnings History

Analyze the earnings history of DexCom using advanced sorting and filters.

Loading calendar...

DexCom (DXCM) Earnings Per Share

The chart below shows DexCom's reported EPS compared to analyst estimates over recent quarters.

DexCom (DXCM) Revenue

The chart below shows DexCom's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is DexCom (NASDAQ:DXCM) reporting earnings?

DexCom (DXCM) is scheduled to report earnings on April 30, 2026. The last reported earnings were for reported on February 12, 2026 for Q4.

What were the latest earnings per share (EPS) for DexCom (NASDAQ:DXCM)?

The Actual EPS was $0.68, which beat the estimate of $0.65.

What were DexCom’s (NASDAQ:DXCM) revenues?

The Actual Revenue was $1.26B, which beat the estimate of $1.25B.

People Also Watch

Envista Holdings Corp

NYSE:NVST

$27.13

-0.91%

Koninklijke Philips NV

Becton Dickinson & Co

NYSE:BDX

$155.29

-0.29%

DexCom Earnings Estimates, EPS & Revenue | NASDAQ:DXCM

DexCom (DXCM) is scheduled to report Q1 earnings on April 30, 2026. Analysts estimate EPS of $0.47 and quarterly revenue of $1.18B.

In the most recent quarter (Q4), DexCom reported EPS of $0.68, beating estimates of $0.65 by 0.05%. Revenue came in at $1.26B, exceeding the estimate of $1.25B by 0.01%.

DexCom has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, DexCom has averaged an EPS surprise of 0.05% and a revenue surprise of 0.02%.

Earnings Date

Apr 30

EPS Estimate

$0.470

Quarterly Revenue Estimate

$1.18B

Annual Revenue
(as of Dec 31)

$4.66B